|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 April 2013 |
|
Main ID: |
NCT01424579 |
|
Date of registration:
|
24/08/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Diacutaneous Fibrolysis and Subacromial Syndrome
|
|
Scientific title:
|
Effectiveness of Diacutaneous Fibrolysis for the Treatment of Subacromial Impingement Syndrome: a Randomised Controlled Trial |
|
Date of first enrolment:
|
February 2008 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01424579 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Spain
| | | | | | | |
|
Contacts
|
|
Name:
|
Carlos López-de-Celis, DO, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Institut Català de la Salut |
|
|
Name:
|
Martín Barra-López, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Institut Català de la Salut |
|
|
Name:
|
Gabriela Fernández-Jentsch, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Servicio Gallego de Salud |
|
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
- Over 18 years
- Diagnosed of Subacromial Impingement Syndrome
- Signed a written consent form.
Exclusion criteria:
- Damaged skin and/or cutaneous lesions in the shoulder area,
- A concomitant treatment with platelet antiaggregant agents
- Acute inflammatory conditions in the shoulder
- Previous shoulder surgery
- A pending litigation or court claim
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Subacromial Impingement Syndrome
|
|
Intervention(s)
|
|
Other: Actual Diacutaneous Fibrolysis
|
|
Other: Placebo Diactuaneous Fibrolysis
|
|
Other: Protocolized physiotherapeutic Treatment
|
|
Primary Outcome(s)
|
|
Changes from Baseline in Pain intensity at 3 weeks and 3 months
[Time Frame: Baseline -3 weeks - 3 months.]
|
|
Secondary Outcome(s)
|
|
Changes from Baseline in Active Range of Motion at 3 weeks and 3 months
[Time Frame: Baseline - 3 weeks - 3 months]
|
|
Changes from Baseline in Functional status at 3 weeks and 3 months
[Time Frame: Baseline - 3 weeks - 3 months]
|
|
Secondary ID(s)
|
|
CEIC-P07/22
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|